French life sciences company bioMérieux – which recently hosted a ribbon cutting for its $60 million Durham facility expansion– has received U.S. Food and Drug Administration clearance for a new version of its BacT/ALERT VIRTUO blood culturing machine aimed at fighting antibiotic resistance.
The new version of the machine is fully automated, according to the company, enabling its additional use at smaller hospitals and clinics. It allows for any lab worker – regardless of their training –…
French life sciences company bioMérieux – which recently hosted a ribbon cutting for its $60 million Durham facility expansion– has received U.S. Food and Drug Administration clearance for a new version of its BacT/ALERT VIRTUO blood culturing machine aimed at fighting antibiotic resistance.
The new version of the machine is fully automated, according to the company, enabling its additional use at smaller hospitals and clinics. It allows for any lab worker – regardless of their training –…